Topics

All Patients Enrolled in Enzymatica's German Placebo-controlled Multicentre Study With ColdZyme

03:07 EDT 3 May 2019 | FinanzNachrichten

STOCKHOLM, May 3, 2019 /PRNewswire/ -- Enzymatica has now finalized the enrolment to its prospective double-blind, placebo-controlled multicentre study to evaluate the effects of ColdZyme on the c...

Original Article: All Patients Enrolled in Enzymatica's German Placebo-controlled Multicentre Study With ColdZyme

NEXT ARTICLE

More From BioPortfolio on "All Patients Enrolled in Enzymatica's German Placebo-controlled Multicentre Study With ColdZyme"

Quick Search